Brief: Tempest Therapeutics Files Prospectus Related To Proposed Resale Of Up To 6,355,932 Shares
16/05/2022 23:17
May 16 (Reuters) - Tempest Therapeutics Inc TPST.O :
* TEMPEST THERAPEUTICS INC FILES PROSPECTUS RELATED TO
PROPOSED
RESALE FROM TIME TO TIME OF UP TO 6,355,932 SHARES OF COMMON
STOCK - SEC FILING
Source text for Eikon: [https://bit.ly/3yKAKps]
Further company coverage: TPST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempest Therapeutics
See all newsBrief: Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing
Tempest Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tempest Therapeutics - Enters $50 Million Common Stock Purchase Agreement With Lincoln Park
Tempest Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Tempest Announces Development Collaboration With Senlang Biotechnology For TPST-4003, A CD7-Targeted Next-Generation In Vivo CAR-T